Lincoln National Corp Amgen Inc Transaction History

Lincoln National Corp

$3.11 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$268.87 - $324.56 $246,822 - $297,946	918 Added 6.79%	14,434 $4.1 Million
Q4 2023 Feb 06, 2024	BUY	$255.7 - $288.46 $430,854 - $486,055	1,685 Added 14.24%	13,516 $3.89 Million
Q3 2023 Nov 03, 2023	BUY	$218.65 - $271.46 $263,691 - $327,380	1,206 Added 11.35%	11,831 $3.18 Million
Q2 2023 Aug 04, 2023	BUY	$214.27 - $253.37 $140,989 - $166,717	658 Added 6.6%	10,625 $2.36 Million
Q1 2023 May 01, 2023	BUY	$225.79 - $275.2 $79,026 - $96,320	350 Added 3.64%	9,967 $2.41 Million
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $257,658 - $327,386	1,125 Added 13.25%	9,617 $2.53 Million
Q3 2022 Nov 03, 2022	BUY	$224.46 - $253.15 $92,028 - $103,791	410 Added 5.07%	8,492 $1.91 Million
Q2 2022 Aug 02, 2022	SELL	$230.71 - $256.74 $93,437 - $103,979	-405 Reduced 4.77%	8,082 $1.97 Million
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $1,096 - $1,212	5 Added 0.06%	8,487 $2.05 Million
Q4 2021 Jan 26, 2022	SELL	$198.88 - $227.6 $156,120 - $178,666	-785 Reduced 8.47%	8,482 $1.91 Million
Q3 2021 Nov 05, 2021	SELL	$212.27 - $248.7 $125,663 - $147,230	-592 Reduced 6.0%	9,267 $1.97 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $135,709 - $150,560	-581 Reduced 5.57%	9,859 $2.4 Million
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $121,384 - $141,454	547 Added 5.53%	10,440 $2.6 Million
Q4 2020 Feb 05, 2021	BUY	$216.38 - $257.67 $206,859 - $246,332	956 Added 10.7%	9,893 $2.27 Million
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $55,612 - $61,845	237 Added 2.72%	8,937 $2.27 Million
Q2 2020 Jul 31, 2020	BUY	$197.81 - $242.74 $201,568 - $247,352	1,019 Added 13.27%	8,700 $2.05 Million
Q1 2020 Apr 24, 2020	SELL	$182.24 - $241.7 $130,301 - $172,815	-715 Reduced 8.52%	7,681 $1.56 Million
Q4 2019 Feb 07, 2020	BUY	$189.21 - $243.2 $247,865 - $318,592	1,310 Added 18.49%	8,396 $2.02 Million
Q3 2019 Nov 06, 2019	BUY	$174.11 - $208.62 $100,635 - $120,582	578 Added 8.88%	7,086 $1.37 Million
Q2 2019 Aug 06, 2019	BUY	$166.7 - $195.41 $53,177 - $62,335	319 Added 5.15%	6,508 $1.2 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $13,926 - $15,698	-77 Reduced 1.23%	6,189 $1.18 Million
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $31,398 - $36,652	176 Added 2.89%	6,266 $1.22 Million
Q3 2018 Nov 06, 2018	BUY	$185.29 - $208.89 $21,123 - $23,813	114 Added 1.91%	6,090 $1.26 Million
Q2 2018 Aug 08, 2018	BUY	$166.05 - $186.51 $29,224 - $32,825	176 Added 3.03%	5,976 $1.1 Million
Q1 2018 May 09, 2018	BUY	$169.43 - $198.0 $24,059 - $28,116	142 Added 2.51%	5,800 $988,000
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $479,701 - $535,972	2,842 Added 100.92%	5,658 $984,000
Q3 2017 Oct 31, 2017	SELL	$167.29 - $191.0 $50,019 - $57,109	-299 Reduced 9.6%	2,816 $525,000
Q2 2017 Aug 07, 2017	BUY	N/A	3,115	3,115 $537,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.

Account